BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28499746)

  • 1. Comparing Access to Laser Capsulotomy Performed by Optometrists and Ophthalmologists in Oklahoma by Calculated Driving Distance and Time.
    Mahr MA; Erie JC
    Ophthalmology; 2017 Sep; 124(9):1290-1295. PubMed ID: 28499746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Access to Ophthalmologists in States Where Optometrists Have Expanded Scope of Practice.
    Stein JD; Kapoor KG; Tootoo JL; Li R; Wagner A; Andrews C; Miranda ML
    JAMA Ophthalmol; 2018 Jan; 136(1):39-45. PubMed ID: 29167903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating Access to Laser Eye Surgery by Driving Times Using Medicare Data and Geographical Mapping.
    Shaffer J; Rajesh A; Stewart MW; Lee AY; Miller DD; Lee CS; Francis CE
    JAMA Ophthalmol; 2023 Aug; 141(8):776-783. PubMed ID: 37471084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating Access to Eye Care in the Contiguous United States by Calculated Driving Time in the United States Medicare Population.
    Lee CS; Morris A; Van Gelder RN; Lee AY
    Ophthalmology; 2016 Dec; 123(12):2456-2461. PubMed ID: 27633646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eye Care Provider Availability for the Medicare Population in U.S. States That Have Expanded Optometrist Scope of Practice.
    Gibson DM
    Optom Vis Sci; 2020 Nov; 97(11):929-935. PubMed ID: 33110024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Joint Management of Cataract Surgery by Ophthalmologists and Optometrists.
    Erie JC; Hodge DO; Mahr MA
    Ophthalmology; 2016 Mar; 123(3):505-13. PubMed ID: 26681394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Outcomes of Laser Trabeculoplasty Performed by Optometrists vs Ophthalmologists in Oklahoma.
    Stein JD; Zhao PY; Andrews C; Skuta GL
    JAMA Ophthalmol; 2016 Oct; 134(10):1095-1101. PubMed ID: 27467233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Geographic and Provider Variations in Ocular Hypotensive Medication Claims Among Medicare Part D Enrollees.
    Janetos TM; French DD; Beaumont JL; Tanna AP
    J Glaucoma; 2019 Feb; 28(2):e29-e33. PubMed ID: 30358645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in characteristics of Medicare patients treated by ophthalmologists and optometrists.
    Miller DD; Stewart MW; Gagne JJ; Wagner AL; Lee AY
    PLoS One; 2020; 15(9):e0227783. PubMed ID: 32925977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of eye care services among the 1991 Medicare population.
    Ellwein LB; Friedlin V; McBean AM; Lee PP
    Ophthalmology; 1996 Nov; 103(11):1732-43. PubMed ID: 8942864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Access to Pediatric Eye Care Following Vision Screening.
    Chung M; Robinson B; Fukuda M; Dunbar JA; Ulangca RA; Khazaeni LM
    J Pediatr Ophthalmol Strabismus; 2022; 59(6):369-374. PubMed ID: 35275779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ophthalmologist and Optometrist Glaucoma Prescribing Patterns Based on 2015 Medicare Part D Data.
    Priluck AZ; Dietze J
    Ophthalmol Glaucoma; 2019; 2(1):63-66. PubMed ID: 32672560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Access to Pediatric Eye Care by Practitioner Type, Geographic Distribution, and US Population Demographics.
    Siegler NE; Walsh HL; Cavuoto KM
    JAMA Ophthalmol; 2024 May; 142(5):454-461. PubMed ID: 38602687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. National Trends in the United States Eye Care Workforce from 1995 to 2017.
    Feng PW; Ahluwalia A; Feng H; Adelman RA
    Am J Ophthalmol; 2020 Oct; 218():128-135. PubMed ID: 32445703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Ophthalmologist Use of Antivascular Endothelial Growth Factor Therapy Among Medicare Beneficiaries.
    Thakore RV; Greenberg PB; Behrens JJ; French DD
    JAMA Ophthalmol; 2016 Sep; 134(9):1071-2. PubMed ID: 27366859
    [No Abstract]   [Full Text] [Related]  

  • 16. COUNTY-LEVEL ANALYSIS OF EYE EXAM ACCESS AND UTILIZATION IN THE UNITED STATES.
    Bhatnagar A; Skrehot H; Ahmed M
    Ophthalmic Epidemiol; 2024 Apr; 31(2):152-158. PubMed ID: 37227243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Variation of Intravitreal Injection Rates and Medicare Anti-Vascular Endothelial Growth Factor Payments per Injection in the United States.
    Erie JC; Barkmeier AJ; Hodge DO; Mahr MA
    Ophthalmology; 2016 Jun; 123(6):1257-62. PubMed ID: 26976701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Australian practice patterns for glaucoma management.
    Newman AR; Andrew NH
    Clin Exp Ophthalmol; 2019 Jul; 47(5):571-580. PubMed ID: 30549194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the Medicare Modernization Act of 2003 and patient wait times and travel distance for chemotherapy.
    Shea AM; Curtis LH; Hammill BG; DiMartino LD; Abernethy AP; Schulman KA
    JAMA; 2008 Jul; 300(2):189-96. PubMed ID: 18612116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Geographic variation in utilization of cataract surgery.
    Javitt JC; Kendix M; Tielsch JM; Steinwachs DM; Schein OD; Kolb MM; Steinberg EP
    Med Care; 1995 Jan; 33(1):90-105. PubMed ID: 7823650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.